Updated hourlyHourly refreshWed, Oct 14, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Energy
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bloom Energy Corporation ("Bloom Energy" or "the Company") (NYSE:BE). Investors who purchased Bloom Energy securities prior to February 27, 2026, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/bloom-energy-corporation-be-derivative_lawsuit. Bloom Energy Investigation Details The investigation concerns whether Bloom Energy and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Bloom Energy Investors? If you are aware of any facts ..
Oct 13 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of lululemon athletica inc. ("lululemon" or "the Company") (NASDAQ:LULU). Investors who purchased lululemon securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/lululemon-athletica-inc-lulu-class_action_lawsuit. lululemon Investigation Details On September 3, 2026, lululemon reported its financial results for the second quarter of fiscal year 2026. Among other items, lululemon reported lower-than-expected revenue and sharply lowered its full-year revenue and earnings guidance. The Company's management attributed its disappointing quarterly results
Oct 13 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Coastal Financial Corporation (NASDAQ:CCB) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Coastal securities between October 28, 2024 and July 29, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/coastal-financial-corporation-ccb-class_action_lawsuit. Coastal Case ..
Oct 13 · 17:05·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG). Investors who purchased Neogen securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/neogen-corporation-neog-class_action_lawsuit. Neogen Investigation Details On September 29, 2026, the U.S. Food and Drug Administration ("FDA") announced that it had issued a warning letter to Neogen "following an investigation that linked a veterinary wound care product labeled as sterile, Neogen Vet HYCOAT (hyaluronate sodium sterile solution), to serious infections and ..
Oct 13 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Alphabet Inc. (NASDAQ:GOOG) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Alphabet securities between May 19, 2026 and July 16, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/alphabet-inc-goog-class_action_lawsuit. Alphabet Case Details The ..
Oct 13 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Liquidia Corporation ("Liquidia" or "the Company") (NASDAQ:LQDA). Investors who purchased Liquidia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/liquidia-corporation-lqda-class_action_lawsuit. Liquidia Investigation Details On October 5, 2026, Liquidia Corporation announced an adverse ruling in United Therapeutics' patent litigation concerning Yutrepia. The court found two of six asserted claims of the '327 patent valid and infringed, raising the possibility of an injunction, restrictions on Yutrepia's availability, and potential removal
Oct 13 · 17:05·PR-Inside
Finance · Real Estate
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fair Isaac Corporation ("Fair Isaac" or "the Company") (NYSE:FICO). Investors who purchased Fair Isaac securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/fair-isaac-corporation-fico-class_action_lawsuit. Fair Isaac Investigation Details On September 28, 2026, the Federal Housing Finance Agency announced changes intended to simplify mortgage pricing and expand the use of alternative credit scoring models in mortgage underwriting. Following the announcement, Rocket Mortgage stated that it would use VantageScore 4.0, a ..
Oct 13 · 17:05·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of uniQure N.V. ("uniQure" or "the Company") (NASDAQ:QURE). Investors who purchased uniQure securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/uniqure-nv-qure-class_action_lawsuit. uniQure Investigation Details On September 29, 2026, uniQure released 48-month clinical data for AMT-130, its investigational gene therapy for Huntington's disease. Although the Company reported continued evidence of slowed disease progression, the four-year results did not meet a key statistical measure and appeared less favorable than the earlier ..
Oct 13 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra LifeSciences" or "the Company") (NASDAQ:IART). Investors who purchased Integra LifeSciences securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/integra-lifesciences-holdings-corporation-iart-class_action_lawsuit. Integra LifeSciences Investigation Details On October 2, 2026, Integra LifeSciences Holdings Corporation lowered its full-year 2026 guidance and reported preliminary third-quarter revenue below analyst estimates. The Company attributed the guidance reduction and revenue shortfall to
Oct 13 · 17:05·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Netcapital Inc. ("Netcapital" or "the Company") (NASDAQ:NCPL). Investors who purchased Netcapital securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/netcapital-inc-ncpl-class_action_lawsuit. Netcapital Investigation Details On August 10, 2026, Reuters reported that the U.S. Securities and Exchange Commission charged Netcapital with securities fraud in connection with an alleged scheme to overstate the Company's revenue. According to Reuters, the SEC alleged that Netcapital improperly recorded nearly $14 million in revenue from ..
Oct 13 · 17:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Embecta Corp. ("Embecta" or "the Company") (NASDAQ:EMBC). Investors who purchased Embecta securities prior to November 25, 2026, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/embecta-corp-embc-derivative_lawsuit. Embecta Investigation Details The investigation concerns whether Embecta and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Embecta Investors? If you are aware of any facts relating to this investigation or purchased ..
Oct 13 · 17:04·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Investors who purchased Humana securities prior to June 27, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HUM. Humana Investigation Details The investigation concerns whether Humana and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Humana Investors? If you are aware of any facts relating to this investigation or purchased ..
Oct 13 · 17:04·PR-Inside